Medications for Anemia Treatment Flashcards

1
Q

When should iron supplementation be employed?

A

TSAT < 30%
Serum ferritin <500 ng/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When can oral iron be used?

A

Oral iron will not be sufficient in patients undergoing hemodialysis

-Can be used for CKD patients or peritoneal dialysis patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are examples of oral iron medications?

A

Ferrous salts (sulfate, gluconate, fumerate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What dosing is used for oral iron?

A

200mg of elemental iron per day at least

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some considerations when using oral iron as a treatment?

A

-Best absorbed in an acidic environment!

-Can be taken with orange juice (unless patient is taking a megavitamin with Vitamin C)

-Is not enteric coated a this would prevent absorption in the acidic stomach

-Should not be used in patients who take medications that affect the acidity of the stomach (H2 blockers, PPI)

-Separate from calcium by 2 hours!

-Can cause upset stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why do we switch to oral iron in ESKD?

A

Hepcidin blocks FPN in the liver which prevents patients from being able to absorb the iron into their bloodstream

**Dialysis is not the reason why we switch, even though the switch often occurs when a patient goes on dialysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the 5 IV iron agents?

A

1) Iron dextran (InFed, Dexferrum)
2) Sodium ferric gluconate (Ferrlicit)
3) Iron sucrose (Venofer)
4) Ferric carboxymaltose (Injectafer)
5) Ferumoxytol (Feraheme)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some considerations when using IV Iron dextran (InFed, Dexferrum)?

A

-CHEAP
-Needs test dose (25 mg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some considerations when using Iron sucrose (Venofer)?

A

Has a second indication for non-dialysis chronic kidney disease patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some considerations when using Ferumoxytol (Feraheme)?

A

Supaparamagnetic compound
*Not a good choice if patient is going to have MRI’s!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is Triferic (ferric pyrophosphate citrate)?

A

An iron compound added to dialysate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When should Erythropoiesis Stimulating Agents (ESAs) be used to treat anemia?

A

After all other correctable causes of anemia have been addressed

*To raise Hb

*Used to prevent a blood transfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

At what lab values should ESAs be started?

A

CKD 3-5: Hb< 10g/dL, Hb falling at rapid rate
CKD 5: Hb between 9 and 10 g/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What warning is associated with ESA use and how long you should use it?

A

Do not use ESA to push Hb above 11.5 g/dL

*increased risk of cardiovascular events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the 3 kinds of Erythropoiesis Stimulating Agents (ESAs)?

A

1) Recombinant human erythropoietin (rHuEPO, epoetin alfa, Epogen, Procrit EPO)
2) Darbepoetin alfa (Aranesp)
3) Methoxy polyethylene glycol-epoetin beta (Mircera)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which ESA has the longest half-life?

A

Methoxy polyethylene glycol-epoetin beta (Mircera)

17
Q

What is the main adverse effect that can occur when taking ESAs?

A

23% of patients will develop high blood pressure

*But if we do not give them this medication they will likely die, so we just have to monitor patients closely

18
Q

What is a major cause of ESA therapy failure?

A

Lack of vitamins or IRON

19
Q

Can ESAs be used in combination with iron supplements?

A

Yes, PSA is often used with iron because when more red blood cells are being generated, the need for iron increases

20
Q

When should Hypoxia Inducible Factor (HIF) Prolyl Hydroxylase Inhibitors (PHI) (HIF-PHIs) be used?

A

For the treatment of anemia due to chronic kidney disease in patients who have been on dialysis for at least 4 months

21
Q

What is the name of the singular HIF-PHI drug?

A

Daprodustat (Jesduvroq)

22
Q

What is the role of hypoxia-inducible factor in anemia?

A

Promotes gene transcription of erythropoietin (EPO)that is necessary for the maturation of red blood cells

23
Q

What are the considerations associated with Daprodustat (Jesduvroq) use?

A

-Discontinue use if the hemoglobin (Hb) >12 g/dL
-Decrease dose by 1/2 if patient has any hepatic impairment
-Do not give with strong CYP2C8 inhibitors

24
Q

Which of the following IV products requires a test dose the first time it is administered?
A. iron sucrose
B. iron dextran
C. sodium ferric gluconate
D. ferrous sulfate

A

B. iron dextran